Transaction · 0000950170-25-012094

Christian Waage

Christian Waage, DIR, reported a transaction classified as grant at HERON THERAPEUTICS, INC. /DE/ involving 35900.000000 shares for an estimated $62107.00. Reported holdings after the transaction were 35900.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
HRTXHERON THERAPEUTICS, INC. /DE/
Filing timeFeb 03
Trade dateJan 30, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

HRTX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
HRTX since 2025-02-03Filed 578 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0000950170-25-012094
Stock Option (Right to Buy)
Transaction date
Jan 30, 2025
Filed Feb 03, 2025, 04:32 PM · 4d delay
Shares
35.9k sh
$173 per share
Estimated value
$6.21M
Computed from shares × price
Holdings after
35.9k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.

  2. F2

    The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.

Original filing · 0000950170-25-012094
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

HRTX